Typhoid fever in an inner city hospital: A 5-year retrospective review

Journal of Travel Medicine

Volumn 20, Issue 1, 2013, Pages 17-21

  Farmakiotis, Dimitrios ^a   Varughese, Julie ^a   Sue, Paul ^b   Andrews, Phyllis ^a   Brimmage, Mary ^c   Dobroszycki, Joanna ^b   Coyle, Christina M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Infectious Disease Service   (United States)

^c JACOBI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; MACROLIDE; NALIDIXIC ACID; QUINOLONE DERIVATIVE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; BANGLADESH; BLOOD CULTURE; CHILD; CLINICAL ARTICLE; DISEASE COURSE; EOSINOPHIL COUNT; FEMALE; HOSPITALIZATION; HUMAN; HYPERTRANSAMINASEMIA; IMMIGRANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MEDICAL RECORD REVIEW; PAKISTAN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; REVIEW; SALMONELLA TYPHI; SCHOOL CHILD; TYPHOID FEVER;

ADOLESCENT; AGE FACTORS; ANTI-BACTERIAL AGENTS; BANGLADESH; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; DRUG RESISTANCE, BACTERIAL; EARLY DIAGNOSIS; EMIGRANTS AND IMMIGRANTS; EOSINOPHILS; FEMALE; HOSPITALIZATION; HUMANS; IMMUNIZATION SCHEDULE; LEUKOCYTE COUNT; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; NALIDIXIC ACID; PAKISTAN; QUINOLONES; RISK FACTORS; SALMONELLA TYPHI; TRAVEL; TYPHOID FEVER;

EID: 84871606853     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2012.00665.x     Document Type: Review

References (35)

1. Parry C, Dougan G, White NJ, Farrar JJ,. Typhoid fever. N Engl J Med 2002; 347: 1770-1782.
2. Crump J, Mintz E,. Global trends in typhoid and paratyphoid fever. Clin Infect Dis 2010; 50: 241-246.
3. Lesser CF, Miller SI,. Salmonellosis [enteric/typhoid fever]. In:, Kasper DL, Braunwald E, Fauci AS, et al., eds. Harrison's principles of internal medicine. Vol. 1. Philadelphia, PA: BC Decker, 2005: 897-900.
4. Ivanoff B,. Typhoid fever: global situation and WHO recommendations. Southeast Asian J Trop Med Public Health 1995; 26 (Suppl 2): 1-6.
5. Hagmann S, Neugebauer R, Schwartz E, et al. Illness in children after international travel: analysis from the GeoSentinel Surveillance Network. Pediatrics 2010; 125: e1072-e1080.
6. Wilson ME, Weld LH, Boggild A, et al. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis 2007; 44: 1560-1568.
7. Jesudasan MV, Jacob John T,. Multi resistant Salmonella typhi in India. Lancet 1990; 336: 252.
8. Kumar S, Rizvi M, Berry N,. Rising prevalence of enteric fever due to multi-drug resistant Salmonella: an epidemiological study. Med Microbiol 2008; 57: 1247-1250.
9. Bhan MK, Bahl R, Bhatnagar S,. Typhoid and paratyphoid fever. Lancet 2005; 326: 749-762.
10. Bhutta ZA,. Current concepts in the diagnosis and treatment of typhoid fever. Br Med J 2006; 333: 78-82.
11. Ullah Z, Ahmed W, Khan AM, et al. Effects of pefloxacin in multi-drug resistant typhoid fever. Pak J Pharm Sci 2005; 18: 61-64.
12. Threlfall EJ, Ward LR, Skinner JA, et al. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet 1999; 353: 1590-1591.
13. Adamson R, Reddy V, Jones L, et al. Epidemiology and burden of hepatitis A, malaria and typhoid in New York City associated with travel: implications for public health policy. Am J Public Health 2010; 100: 1249-1252.
14. Lynch MF, Blanton EM, Bulens S, et al. Typhoid fever in the United States, 1999-2006. JAMA 2009; 302: 859-865.
15. Connor BA, Schwartz E,. Typhoid and paratyphoid fever in travellers. Lancet Infect Dis 2005; 5: 623-628.
16. Steinberg EB, Bishop R, Haber P, et al. Typhoid fever in travelers: who should be targeted for prevention? Clin Infect Dis 2004; 39: 186-191.
17. Angell SY, Cetron MS,. Health disparities among travelers visiting friends and relatives abroad. Ann Intern Med 2005; 142: 67-72.
18. Leder K, Tong S, Weld L, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis 2006; 43: 1185-1193.
19. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354: 119-130.
20. Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985-1994. Arch Intern Med 1998; 158: 633-638.
21. Meltzer E, Sadik C, Schwartz E,. Enteric fever in Israeli travelers: a nation-wide study. J Travel Med 2005; 12: 275-281.
22. Vollaard AM, Ali S, Widjaja S, et al. Identification of typhoid fever and paratyphoid fever cases at presentation in outpatient clinics in Jakarta, Indonesia. Trans R Soc Trop Med Hyg 2005; 99: 440-450.
23. Passos J,. Aneosinophilia in typhoid fever. An Inst Med Trop (Lisb) 1953; 10: 999-1001.
24. Khosla SN, Anand A, Singh U, Khosla A,. Haematological profile in typhoid fever. Trop Doct 1995; 25: 156-158.
25. Kundu R, Ganguly N, Ghosh TK, et al. IAP Task Force Report: diagnosis of enteric fever in children. Indian Pediatr 2006; 43: 875-883.
26. Hunziker T, Berger C, Staubli G, et al. Profile of travel-associated illness in children, Zürich, Switzerland. J Travel Med 2012; 19: 158-162.
27. Bui YG, Trépanier S, Milord F, et al. Cases of malaria, hepatitis A, and typhoid fever among VFRs, Quebec (Canada). J Travel Med 2011; 18: 373-378.
28. Kozicki M, Steffen R, Cheer M,. "Boil it, cook it, peel it or forget it": does this rule prevent traveller's diarrhea? Int J Infect Dis 1985; 15: 169-172.
29. Luxemburger C, Dutta AK,. Overlapping epidemiologies of hepatitis A and typhoid fever: the needs of the traveler. J Travel Med 2005; 12: S12-S21.
30. Schwartz E, Jenks N, Shlim D,. "Typhoid hepatitis" or typhoid fever and acute viral hepatitis. Trans R Soc Trop Med Hyg 1994; 88: 437-438.
31. Parry CM, Ho VA, Phuong le T, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 2007; 51: 819-825.
32. Meltzer E, Leshem E, Stienlauf S, et al. Combination therapy with ceftriaxone and azithromycin for Salmonella paratyphi A bacteremia among Israeli travelers to Nepal. Presentation PO 03.08 at the 12th International Conference of the International Society of Travel Medicine, Boston, 2011.
33. Engels EA, Falagas ME, Lau J, Bennish ML,. Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. Br Med J 1998; 310: 110-116.
34. Hirschel B, Wuthrich R, Somaini B, Steffen R,. Inefficacy of the commercial live oral Ty 21a vaccine in the prevention of typhoid fever. Eur J Clin Microbiol 1985; 4: 295-298.
35. Whitaker JA, Franco-Paredes C, Del Rio C, Edupuganti S,. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas. J Travel Med 2009; 16: 46-52.